Alberto Cliquet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alberto Cliquet has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Rozim Zorzi
Hospital Israelita Albert Einstein São Paulo SP Brazil Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
1 shared publication - Claudiane A. Fukuchi
Department of Orthopedics and Traumatology, Faculty of Medical Sciences, University of Campinas-UNICAMP, São Paulo 13083-970, Brazil
1 shared publication - Glenda Feldberg
Hemophilia Treatment Center (HTC) “Cláudio Luiz Pizzigatti Corrêa” Hemocentro UNICAMP University of Campinas Campinas SP Brazil
1 shared publication - Gustavo Constantino de Campos
Universidade Estadual de Campinas (UNICAMP)
1 shared publication - Janaina B. S. Ricciardi
Hemophilia Treatment Center (HTC) ‘Cláudio Luiz Pizzigatti Corrêa’, University of Campinas–UNICAMP, São Paulo 13083-878, Brazil
1 shared publication - Reginaldo Kisho Fukuchi
Biomedical Engineering Program, Universidade Federal do ABC, São Bernardo do Campo, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 29 September 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (10) , 1050
Current Concepts in Viscosupplementation: New Classification System and Emerging Frontiers
Viscosupplementation with intra-articular hyaluronic acid (HA) is a key therapeutic option for osteoarthritis (OA), yet the field is hampered by clinical controversies and an outdated classification of available products. This comprehensive review critically analyzes the current landscape, moving from a mechanical to a biological paradigm of HA’s mechanism of action. We argue that the traditional HA product classification based solely on molecular weight is insufficient, as it conflates chemically distinct products. Therefore, we propose a new, two-tiered classification framework: the primary distinction is based on chemical structure, separating linear (non-modified) HA from cross-linked (chemically modified) HA. Linear HA is then sub-classified by molecular weight (Low, Intermediate, and High), while cross-linked HA is defined as a separate category of hydrogels with a ultra-high effective molecular weight. Within this clearer framework, we analyze the central controversy between formulations, highlighting the pivotal emergence of high-concentration, high-molecular-weight (>2 million Dalton) linear HA. These formulations not only challenge the durability rationale for cross-linking by providing year-long efficacy but also possess a superior biological profile for chondroprotection, preserving chondrocyte viability and function. Furthermore, we explore the expanding frontier of combination therapies, where linear HA serves as the ideal physiological scaffold for agents like corticosteroids, PRP and other injectable orthobiologics such as bone marrow aspirate and stromal vascular fraction.
- 29 September 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (10) , 1050
Open AccessCurrent Concepts in Viscosupplementation: New Classification System and Emerging Frontiers
Viscosupplementation with intra-articular hyaluronic acid (HA) is a key therapeutic option for osteoarthritis (OA), yet the field is hampered by clinical controversies and an outdated classification of available products. This comprehensive review critically analyzes the current landscape, moving from a mechanical to a biological paradigm of HA’s mechanism of action. We argue that the traditional HA product classification based solely on molecular weight is insufficient, as it conflates chemically distinct products. Therefore, we propose a new, two-tiered classification framework: the primary distinction is based on chemical structure, separating linear (non-modified) HA from cross-linked (chemically modified) HA. Linear HA is then sub-classified by molecular weight (Low, Intermediate, and High), while cross-linked HA is defined as a separate category of hydrogels with a ultra-high effective molecular weight. Within this clearer framework, we analyze the central controversy between formulations, highlighting the pivotal emergence of high-concentration, high-molecular-weight (>2 million Dalton) linear HA. These formulations not only challenge the durability rationale for cross-linking by providing year-long efficacy but also possess a superior biological profile for chondroprotection, preserving chondrocyte viability and function. Furthermore, we explore the expanding frontier of combination therapies, where linear HA serves as the ideal physiological scaffold for agents like corticosteroids, PRP and other injectable orthobiologics such as bone marrow aspirate and stromal vascular fraction.
- Open Access
- 31 March 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (2) , 112-118
Biomechanical Gait Analysis of an Adult with Severe Hemophilia: A Case Report
Hemophilia is characterized by recurrent bleeding into the joints leading to irreversible chronic arthropathy with reduced joint range of motion (ROM), which may lead to changes in gait patterns. To analyze the gait pattern in a 35-year-old male with severe hemophilia A, three-dimensional biomechanical analysis was performed during overground walking. The control group data from a public gait dataset of 10 healthy male individuals were used for comparison. The clinical examination was assessed with the Functional Independence Score in Hemophilia (FISH), Haemophilia Activities List (HAL), and Hemophilia Joint Health Score (HJHS). The biomechanical analysis demonstrated a pattern for both left knee and ankle joints with greater similarity to the control group compared to the right knee and ankle joints. ROM based on the HJHS questionnaire also showed greater impairment of the right-side knee joint compared to the left-side knee joint. This unique pattern could be the result of a compensation mechanism due to limited movement during the walking task and the surgical treatment.
- 31 March 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (2) , 112-118
Open AccessBiomechanical Gait Analysis of an Adult with Severe Hemophilia: A Case Report
Hemophilia is characterized by recurrent bleeding into the joints leading to irreversible chronic arthropathy with reduced joint range of motion (ROM), which may lead to changes in gait patterns. To analyze the gait pattern in a 35-year-old male with severe hemophilia A, three-dimensional biomechanical analysis was performed during overground walking. The control group data from a public gait dataset of 10 healthy male individuals were used for comparison. The clinical examination was assessed with the Functional Independence Score in Hemophilia (FISH), Haemophilia Activities List (HAL), and Hemophilia Joint Health Score (HJHS). The biomechanical analysis demonstrated a pattern for both left knee and ankle joints with greater similarity to the control group compared to the right knee and ankle joints. ROM based on the HJHS questionnaire also showed greater impairment of the right-side knee joint compared to the left-side knee joint. This unique pattern could be the result of a compensation mechanism due to limited movement during the walking task and the surgical treatment.